Unknown

Dataset Information

0

Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.


ABSTRACT: Antibody VRC01 is a human immunoglobulin that neutralizes about 90% of HIV-1 isolates. To understand how such broadly neutralizing antibodies develop, we used x-ray crystallography and 454 pyrosequencing to characterize additional VRC01-like antibodies from HIV-1-infected individuals. Crystal structures revealed a convergent mode of binding for diverse antibodies to the same CD4-binding-site epitope. A functional genomics analysis of expressed heavy and light chains revealed common pathways of antibody-heavy chain maturation, confined to the IGHV1-2*02 lineage, involving dozens of somatic changes, and capable of pairing with different light chains. Broadly neutralizing HIV-1 immunity associated with VRC01-like antibodies thus involves the evolution of antibodies to a highly affinity-matured state required to recognize an invariant viral structure, with lineages defined from thousands of sequences providing a genetic roadmap of their development.

SUBMITTER: Wu X 

PROVIDER: S-EPMC3516815 | biostudies-literature | 2011 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.

Wu Xueling X   Zhou Tongqing T   Zhu Jiang J   Zhang Baoshan B   Georgiev Ivelin I   Wang Charlene C   Chen Xuejun X   Longo Nancy S NS   Louder Mark M   McKee Krisha K   O'Dell Sijy S   Perfetto Stephen S   Schmidt Stephen D SD   Shi Wei W   Wu Lan L   Yang Yongping Y   Yang Zhi-Yong ZY   Yang Zhongjia Z   Zhang Zhenhai Z   Bonsignori Mattia M   Crump John A JA   Kapiga Saidi H SH   Sam Noel E NE   Haynes Barton F BF   Simek Melissa M   Burton Dennis R DR   Koff Wayne C WC   Doria-Rose Nicole A NA   Connors Mark M   Mullikin James C JC   Nabel Gary J GJ   Roederer Mario M   Shapiro Lawrence L   Kwong Peter D PD   Mascola John R JR  

Science (New York, N.Y.) 20110811 6049


Antibody VRC01 is a human immunoglobulin that neutralizes about 90% of HIV-1 isolates. To understand how such broadly neutralizing antibodies develop, we used x-ray crystallography and 454 pyrosequencing to characterize additional VRC01-like antibodies from HIV-1-infected individuals. Crystal structures revealed a convergent mode of binding for diverse antibodies to the same CD4-binding-site epitope. A functional genomics analysis of expressed heavy and light chains revealed common pathways of a  ...[more]

Similar Datasets

2020-01-28 | GSE141498 | GEO
| S-EPMC2529122 | biostudies-literature
| S-EPMC4304871 | biostudies-literature
| S-EPMC4779134 | biostudies-literature
| S-EPMC7341949 | biostudies-literature
| S-EPMC7690876 | biostudies-literature
2020-05-26 | PXD015168 | Pride
| S-EPMC4270772 | biostudies-literature